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INTRODUCTION 
Breast Cancer is the most common site specific cancer in women and is the leading 
cause of death from cancer in women age around 22-59 yrs. It accounts for 26% of 
all newly diagnosed   cancers in females and is responsible for 15% of cancer 
related deaths in females.  
The incidence of breast cancer varies in different countries in the world. Women 
residing in industrialized countries tend to have higher incidence than women 
residing in less industrialized countries. 
Breast Cancer distribution differs by geography, regional lifestyle, racial or ethnic 
background. In general both breast cancer incidence and mortality are relatively 
lower among the female populations of Asia and Africa, relatively underdeveloped 
nations, and nations that have not changed to   the westernized reproductive  and 
dietary  patterns . In contrast, European and North American women from heavily 
industrialized or westernized countries have a substantially higher incidence of 
breast cancer. 
Although often related, the factors that influenced the incidence of breast cancer 
differ from those that affect mortality. Incidence rates are lower among populations 
with females who begin child bearing at young ages and who have multiple full 
term pregnancies and increased duration of breast feeding.  
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These features characterize many underdeveloped nations and also many eastern 
nations. Disparities in breast cancer survival  are closely linked to disparities in 
socio economic status .Poverty rates and proportions of the population that lack 
health care insurance  are some of  the socio economic  factors that create barriers  
to effective breast cancer screening  and result in delayed  breast cancer diagnosis, 
advanced stage distribution, inadequacies in comprehensive treatment and 
ultimately increased mortality rates.   
Long-term survival of women with breast cancer mainly depends upon the stage of 
the disease at the time of presentation. Attempts to control death due to breast 
cancer therefore relied on promoting early detection of cancer and its treatment. A 
Comprehensive breast history, a thorough breast examination, and a clear record of 
findings and follow-up can detect cancer in early stage [9]. 
 Early diagnosis and proper referrals, availability of female doctors, facilities to 
detect breast cancer earlier by mammography as a tool for screening purpose, and 
availabilities of facilities for proper treatment can decrease the mortality rate in CA 
breast [4]. 
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EPIDEMIOLOGY OF BREAST CANCER: 
Breast cancer is most common cancer found in females in Europe (180000 cases 
per year), The United States (130000 cases per year), Australia and many Latin 
American Countries. Breast Cancer is rare before age of 20 -30 years but incidence 
rises very steadily up to age 50 years. Mortality rate due to breast cancer in 
Western Europe and Northern America are of order of 15-25 per Lakh women that 
is 30-40 % of incidence rate [2]. 
The highest incidence rates has occurred in Canada, United States, Spain, 
Sweden(3-6 percent annually) and lowest rate found in Norway and Denmark. 
Breast Cancer rates differ by race and ethnicity. Though American-African women 
have a lower overall incidence of breast cancer compared with Caucasian women, 
African-American have a higher incidence of breast cancer before 35 years of age. 
The reasons for these disparities are not understood but the possible explanations 
include a) Distribution of risk factors  for breast cancer  b) Differential utilization 
of mammographic screening c) Differences in inherent genetic susceptibility d) 
Tumor characteristic differences e) Differential access to treatment  f) Differences 
in prevalence of comorbidities in women diagnosed with carcinoma of breast. 
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The Smith surgical papyrus (3000-2500 B.C) is the first to document about and 
this cancer occurred in men and the author’s conclusion about this cancer is that 
there is no treatment for breast cancer [5]. 
In De Medicina Celsus quoted on the importance of operations for breast cancer of 
earlier stage. “None of these may be removed but the cacoethes (early cancer), the 
rest are irriated by every method of cure. The more violent the operations are, the 
more aggressive they grow” [6]. 
Rudolf Virchow found that CA breast arise from epithelial cells and then spreads 
along lymphatic vessels. He is considered as the architect of new cellular theory on 
pathogenesis of carcinoma breast. 
Le Dran noted that breast carcinoma was a local disease that spreads by lymphatic 
vessels to axillary lymph nodes. In nineteenth century Moore emphasized complete 
resection of breast with removal of axillary lymph nodes which are palpable. In 
1894 both Halsted and Meyer advocated radical mastectomy as treatment of 
carcinoma of breast. In 1948, Patey introduced modified radical mastectomy for of 
treatment of operable breast cancer but advanced.  
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AIMS & OBJECTIVES OF THE STUDY 
1) To analyze the relationship between socio economic and educational status 
and early diagnosis of CA Breast. 
2) To emphasize the need for early detection of breast cancer. 
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ANATOMY OF BREAST  
Breast is a tubulo alveolar type of Modified sweat gland. It is fully formed in 
female and Vestigial in male. It Overlies 2nd to 6th ribs and extends from side of the 
sternum to the anterior axillary line on both sides. Posteriorly breast rest on fascia 
of Pectoralis major, upper end of Rectus sheath, Externaloblique and serratus 
anterior [2]. 
Nipple is a conical prominence in the center of areola devoid of fat, hair or sweat 
glands. Composed of circularly arranged smooth muscle for lactation and erection. 
Areola contains sebaceous glands, sweat glands and accessory glands of 
montgomery for lubrication. 
Retromammary space is space between investing layer of breast and pectoral 
fascia. It contains small amount of fat, lymphatics and small blood vessels. It 
allows breast some degree of movement on pectoral fascia.  
Components of breasts includes Glandular apparatus, fibrous stroma and 
supporting structures, adipose tissue  which contains arteries, veins, lymphatics, 
nerves  and Infiltrating cells. 
Glandular component of the breast consists of ducts which branches radially and 
spreads outward and downward from nipple areola complex. At the summit, 
subareolar ducts widen as lactiferous sinus.  
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Lactiferous ducts exit through 10-15 orifices in the nipple. At the opposite end the 
ducts after progressive branching end in clusters of spaces called terminal 
ductules/acini .These are the milk forming organs of the breast.Each acini with 
their efferent ductules called lobules/lobular acini. Each ductal system is functional 
independent [3]. 
Fibrous stroma contains Cooper’s ligament which is nothing but dense connective 
tissue coursing throughout the fat from skin to underlying deep fascia. It Provides 
shape to the breast and Holds breast upwards. Tethering of this ligament by 
scirrhous carcinoma produces dimple on the surface of breast.  
Fibrous stroma also contains specialized loose connective tissue investing terminal 
lobule which Contain capillaries, lymphocytes, and mononuclear cell infiltrates. 
Fatty tissue fills the gap between glandular apparatus and produces distinguished 
shape of breast. 
Arterial blood supply of breast 
Blood supply of breast is mainly from a) Perforating branches of internal 
mammary artery  through its  perforator branches  b)Lateral branches of 2-4th 
posterior intercostal arteries c) branches of axillary artery which includes, Lateral 
thoracic and pectoral branches of thoraco-acromial artery. The superomedial 
perforating branch of the internal mammary vessels is important and supplies 60% 
of total breast.  
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ARTERIAL BLOOD SUPPLY OF BREAST 
 
 
 
VENOUS DRAINAGE OF BREAST 
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Venous drainage 
Three groups of deep veins that drain the breast are a) Posterior Intercostal veins 
(2nd -4th) through its perforator branches b) Tributaries of Axillary vein c) 
Perforating branches of the internal thoracic vein. Batson’s venous plexus, which 
overlies the vertebrae and extending from skull base to the sacrum, is a route for 
metastastic spread of breast cancer to the vertebrae, skull, pelvis and ribs [2]. 
Nerve supply to the breasts 
Sensory nerve supply of the breast derived from lateral cutaneous branches of the 
3rd to 6th intercostal nerves. The nerves exist the intercostals spaces between slips 
of the muscle serratous anterior. The Sensory nerves supply of skin over the upper 
part of breast is by supraclavicular nerve through its anterior branches. Intercosto 
brachial nerve   is a lateral cutaneous branch of second intercostals nerve which if 
resected leads to sensory loss over medial part of upperarm. 
Lymphatic drainage of breast 
Breast is drained by 2 set of lymphatics 
a) Lymphatics of skin over breast 
b) Lymphatics of the parenchyma of breast  
 More than 75% of lymph drains into axillary lymph nodes   
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FIG: LYMPHATIC DRAINAGE OF BREAST 
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Lymphatics of skin over the breast - drain the integuments over breasts. They do 
not drain areola and nipple. Upper part drains into supraclavicular nodes, Outer 
part drains into axillary nodes and Inner part drains into internal mammary nodes. 
Lymphatics of skin communicate across midline. Mammary cancer spread along 
lymphatics to produce nodules in skin.  
Lymphatic drainage of parenchyma 
Lymph from the breast drains into the following lymph nodes. The axillary  lymph 
node  which consists of six groups a)  Lateral  group that lie medial  to the  
axilliary vein  which receive  lymph drainage  from upper  extremity. b) Anterior  
or  pectoral  group  that lie  along vessels of  thoraco-lateral  and receive  drainage  
of  lymph  from lateral part of  breast. c)  Posterior or Scapular group that lie along 
the subscapular vessels and drains the posterior part of neck, trunk and shoulder. d)  
Central  group  that lie behind the muscle  of pectoralis  minor  and receive lymph 
drainage   from  external  mammary  and scapular  group  of   lymphnodes .e)  
Subclavicular  or  Apical  group  that lie posterior and superior  to pectoralis minor  
muscle. f) The interpectoral (  Rotter’s  Nodes) that are interposed between the 
pectoralis major and minor muscle.  
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Surgical levels of axillary lymph nodes   
Level I include Anterior or Pectoral Group of axillary lymph nodes, Subscapular or 
posterior and   lateral axillary lymph nodes. 
Level II includes Central axillary lymph nodes, some apical axillary lymph nodes 
and Interpectoral lymph nodes (Rotter’s). 
Level III includes Apical or infra clavicular lymph nodes. 
Anatomical significance 
Lymphatic drainage of the mesenchymo epithelial components of breast is the 
principle route for metastasis of adenocarcinoma of breast. A thorough knowledge 
about the anatomy of lymphatic drainage plexus and related lymph nodes of the 
breast is required. It is important for knowing the principles of performing sentinel 
lymph node biopsy or to perform axillary dissection adequately and by safety 
method. 
EMBRYOLOGY 
Development of   breast: 
During  5th or 6th  week of  fetal  development  two vertical ectodermal thickenings 
( mammary ridges, milk lines ) develop in  embryo .Paired  breast  develop  along 
the  ridges    which  starts  from the axilla to the inguinal region[3]. 
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Nipple develops from rostral part of each bridge. The mammary glands develop 
from the nipples during fetal life. Breast develops as ectodermal in growth which 
forms a primary tissue bud in the mesenchyme. 
 From Primary bud 15 to 20 secondary buds develop. Major lactiferous ducts 
develop that ends into a mammary pit which is shallow. The pit is transformed into 
nipple by mesenchymal proliferation.   
Breast  does not fully develop till pubertal age .Then it enlarges due to hormonal 
action of  estrogen and progesterone  that leads to epithelial and connective tissue 
proliferation. 
Breast is not completely developed till females become pregnant. Absence of 
breast (amastia) is rare and it is due to failure in normal development of mammary 
ridge which occurs at 6th   week of intrauterine life.  
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PHYSIOLOGY OF THE BREAST 
Development and function of breast are regulated by various hormonal stimulus by 
Estrogen, Progesterone, Prolactin, Oxytocin, Cortisol, Thyroid Hormone and 
Growth Hormone [8]. 
For normal development and function of breast Estrogen, Progesterone and 
Prolactin are necessary. Estrogen and Progesterone are necessary for epithelial 
differentiation and development of lobules and ducts. Prolactin is responsible for 
lactogenesis in late pregnancy and postpartum period.   
The regulation of release of hormones Estrogen and Progesterone from ovaries is 
by   Gonadotropins luteinizing hormone (LH) and follicle – stimulating hormone 
(FSH).The realease of LH and FSH regulated by secretion of gonadotropins from 
the hypothalamus [2]. 
By negative and positive feedback effects, secretion of FSH, LH and GnRH are 
controlled by circulating Estrogen and Progesterone. With onset of puberty 
sensitivity of hypothalamic-Pituitary axis to negative feedback decreases but 
increases to positive feedback from Estrogen. These sequence of physiological 
events lead to onset of menstruation and leads to an increase in size and density of 
breast, engorgement of breast tissues and proliferation of epithelium. 
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Changes in Breast During pregnancy: 
 There is an increase in circulating estrogen and progesterone which causes 
alteration in form and substance of breast. There is proliferation of Epithelium of 
duct and lobules, darkening of skin of areola and prominence of Montgomery’s 
glands. Minor duct branches during I and II trimesters and develop in III trimester 
leading to accumulation of fat in epithelium of alveoli and alveolar ductal spaces 
filled by colustrum. 
After delivery of placenta the circulating level of estrogen and progesterone 
decreased that permits the prolactin for lactogenesis.  Production of milk and its 
release are regulated by reflex arcs of nerve which begins in the nerve endings of 
nipple and areola .Oxytocin causes cells of myoepithelium to contract and 
compress the alveoli which causes milk to expel into lactiferous sinuses. 
Menopause: 
The level of estrogen and progesterone secreted by ovaries decreases and ducts and 
alveoli of breast involutes. Breast tissues are replaced by fibrous connective tissue 
and adipose tissues. 
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PATHOLOGY OF CARCINOMA BREAST 
The cell of origin: 
The cell of origin of breast cancers is very significant for its implication on   
etiology and treatment. Although the majority of tumor cells would consist of non 
stem cell progeny, only the malignant stem cells would contribute to tumor 
progression or recurrence. Effective treatment would need to target only this 
population, which to date has been difficult to define. The most likely cell type of 
origin for the majority of carcinomas is the ER-expressing luminal cell, since the 
majority of cancers are ER-positive and precursor lesions, such as atypical 
hyperplasias, are most similar to this type of cell. ER-negative carcinomas may 
arise from ER-negative myoepithelial cells [2]. 
Classification 
Most breast malignancies are of adenocarcinoma type that are divided into In situ 
carcinomas and Invasive carcinomas. In Situ carcinomas are subdivided into DCIS 
(80%) and LCIS (20%) .Invasive carcinomas are subdivided into No-special-type 
carcinoma (ductal) (79%) , Lobular carcinoma(10%)   and other types 1%. 
Ductal Carcinoma In Situ (DCIS) 
It consists of   population of malignant clonal cells limited to ducts and lobules by 
the basement membrane. It is histologicaly characterized by epithelial proliferation 
of ducts that leads to growth of papilla within duct lamina. Earlier in the 
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development, the cancer cells donot exhibit nuclear atypical, mitoses or 
pleomorphism which makes differentiation of early DCIS from hyperplasia due to 
benign disease.  
DCIS is classified according to grade of nucleus and presence of necrosis.There is 
fivefold risk in females with DCIS to develop invasive cancer. The invasive 
cancers that develop in DCIS are observed in same quadrant and side of the breast 
where DCIS was initially detected.  
With advent of mammographic screening, diagnosis of DCIS has rapidly 
increased. Detected as a result of calcifications or periductal fibrosis. Five subtypes 
are solid, comedo, cribriform, papillary and micro papillary. 
Lobular Carcinoma In Situ (LCIS) 
LCIS orginate from terminal duct lobules and seen mainly in breast of female.  
LCIS is characterized by cancer cells that distend and alter the terminal duct 
lobules but ratio between nucleus and cytoplasm are normal. Mucoid globules of 
cytoplasm are important pathological feature of LCIS. About 25% of womenwith 
LCIS develop invasive cancer.Invasive cancer develops in any side of the breast 
not depending on initial focus of LCIS.The risk for development of invasive cancer 
is increased in LCIS.  
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LCIS is always an incidental biopsy finding. When both breasts are biopsied, LCIS 
is bilateral in 20% to 40% of cases, compared with 10% to 20% of cases of DCIS. 
LCIS is more common in young women, with 80% to 90% of cases occurring 
before menopause. 
Invasive Carcinoma, No Special Type (NST; Invasive Ductal Carcinoma) 
Includes majority of the carcinomas (70% to 80%). Morphology: firm too hard 
with irregular border. When cut or scraped, they typically produce a characteristic 
grating sound. There is a wide range of histologic appearances.  
Invasive Lobular Carcinoma 
Usually present as a palpable mass or a mammographic density with irregular 
borders. Greater incidence of bilaterality. The histologic hallmark is the presence 
of dyscohesive infiltrating tumor cells, often arranged in single file. Signet-ring 
cells containing an intracytoplasmic mucin droplet are common [2]. 
 Atypical lobular hyperplasia, LCIS, and invasive lobular carcinoma all consist of 
dyscohesive cells with oval or round nuclei and small nucleoli .The cells lack the 
cell adhesion protein E-cadherin. Foote and Stewart originally classified the 
invasive breast cancer as follows 1) Paget’s disease of nipple 2) Ductal carcinoma 
of invasive type 3) Adenocarcinoma with productive fibrosis 4) Medullary 
carcinoma which constitutes 4% 5)Mucinous or colloid carcinoma about 2% 6) 
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Papillary carcinoma 2% 7)Tubular carcinoma 2% 8) Invasive Lobular carcinoma 
about 10% and rare cancers like Adenoidcystic Apocrine. 
Paget’s disease of the Nipple is characterised by presence of chronic, Eczematous 
eruption of the nipple, which converts into an ulcerative and weeping lesion. It 
usually associated with DCIS or invasive cancer. A lump may be present or absent. 
Biopsy from the nipple will show features of pagetoid change .Pathognomic 
feature of this cancer is presence of large, pale, cells with vacuoles (Paget cell) in 
the epithelium of rete pegs are important pathological feature. 
Disease of Paget’s can be differentiated from melanoma of superficial spreading 
type by the presence of CEA immunostaining and presence of S-100 antigen 
immunostaining in melanoma. Surgery is the main treatment for this tumor which 
includes either removal of lump or breast or modified radical mastectomy 
depending on the extent involved and presence or absence of invasive cancer. 
Axillary lymphnode metastasis can occur in about 60 % of cases of invasive ductal 
carcinoma.It occurs mainly in post or perimenopausal women of age group 50 to 
60 years.  
Metastasis 
Lobular carcinomas - different pattern of metastasis. Metastasis to the peritoneum 
and retroperitoneum, the leptomeninges (carcinoma meningitis), the 
gastrointestinal tract, and the ovaries and uterus.Metastatic lobular carcinoma 
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maybe mistaken for signet ring cell carcinoma of the GI tract. Common underlying 
molecular etiology. Characterized by the loss of E-cadherin, a cell adhesion 
molecule that functions as a tumor suppressor.  
OtherTypes: 1)Medullarycarcinoma 2)Mucinous  carcinoma 3)TubularCarcinoma 
4)Invasivepapillarycarcinoma 5)InvasiveMicropapillarycarcinoma 6)Metaplastic 
carcinoma. 
Medullary Carcinoma: 
Medullary carcinoma constitutes only 4% out of all invasive cancers and belongs 
to BRCA1phenotypic carcinoma of breast. Most common in women in the sixth 
decade.It may closely mimic a benign lesion clinically and radiologically.The 
cancer is grossly hemorrhagic and soft.But clinically,it is deepseated within the 
breast and bulky..It can occur bilaterally in 20% of cases.On microscopical 
examination it consists mainly of lymphocytes and plasma cells within a dense 
lymphoreticular infiltrate,active mitosis with large pleomorphic nuclei, minimal 
ductal or alveolar differentiation. It is poorly differentiated, has slightly better 
prognosisand Lymph node metastases are infrequent. 
Mucinous (Colloid) Carcinoma: 
It occurs in older women and tends to grow slowly. It is characterized by 
aggregates of low grade cancer cells which are surrounded by extracellular mucin. 
It appears glistening and gelatinous macroscopically. In microscopic section cancer 
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cells may not be seen if there is more mucinous component. Hence multiple 
section analysis is needed to conform the diagnosis. It is usually diploid, well to 
moderately differentiated, and ER positive. Lymph node metastases are uncommon 
and the overall prognosis is slightly better. 
Tubular carcinoma:  
Tubular carcinomas are diagnosed by mammographic screening and occur mostly 
in perimenopausal women. On microscopical examination tubular elements are 
seen which are arranged haphazardly. Diploid, ER positive, and HER2/neu 
negative have excellent prognosis. Distant metastasis are rare in invasive 
cribriform, carcinoma, axillary lymphnode metastases are rare. 
Papillary & Micro papillary: 
Papillary Carcinoma usually occurs in older age group around 70 years.This tumor 
is usually small attaining 3 cm diameter rarely. This tumor is characterized by 
multilayered epithelium and papillae .Axillary lymphnode metastases are rare. The 
survival rate are similar to tubular and mucinous carcinoma. It is Invasive Papillary 
Carcinoma and usually ER positive. It has Favorable prognosis but Invasive micro 
papillary carcinoma is ER negative and HER2 positive. It has Poor prognosis. 
Modes of Metastasis: 
1) In contiguity spread 2) Lymphatic spread to Axillary and other lymph Nodes3) 
Blood Borne to Bones, Liver, Brain etc.4) Trans-coelomic spread to peritoneum.  
 28 
 
 
RISK FACTORS FOR CA BREAST: 
Family History:  
Breast cancer is 3 to 4 times less likely to occur in females with negative family 
history of breast carcinoma than with positive history of breast cancer in first 
degree relative of their family. Risk is increased  in those cases whose mother or 
sibling’s  breast  cancer  occurred before menopausal age group  or  bilateral 
cancer or in patients with  family history  positive for breast  cancer  where two or 
more first degree relatives are affected with ca breast.BRCA1 and BRCA2 gene 
mutation accounts for less than 10% of  familial breast cancer [6]. 
Reproductive History: 
Early onset of menstrual cycle and menopause at late age contribute to more risk of 
breast cancer but premenopausal oophorectomy reduces the risk.  Women with no 
children and women with pregnancy at fullterm after 35 years have 1.5 times 
incidence higher of carcinoma breast than multiparous. Long period of lactation 
found to decrease the risk of carcinoma breast. Each full term pregnancy leads to 
3% reduction in risk of breast cancer [8]. 
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Menstrual History: 
Late onset of Menstrual cycle and menopause by artificial means found to have 
decreased risk but increase in incidence in patients who attained menarche before 
12 years or attained menopause naturally after 50 years. 
Benign breast condition such as papillomatosis, or hyperplasia of atypical 
epithelium, and density of breast more in mammogram are more prone for 
increased risk of carcinoma breast. 
The women who develops carcinoma in one breast has more chance of getting 
cancer in opposite breast. 
Contralateral breast cancer occurs at rate of 1-2 percent per year in these patients. 
Increased intake of fatty diet can increase the incidence of breast cancer. Long term 
doses of estrogen in women who have attained menopause may have increased risk 
of developing carcinoma of breast. 
Genetics:  
Breast cancers of inherited type are found to be associated with mutation of gene 
present on chromosome 17. BRCA 1 gene mutation is found to be associated with 
increased risk of early onset of cancer of breast and ovary. .Of about   85% of 
females with BRCA 1 gene mutations can develop carcinoma of breast in their life 
time.BRCA1 breast cancer are associated with invasive ductal which are hormone 
receptor negative and poorly differentiated.  Another gene BRCA 2  which is 
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associated with  mutation of gene on chromosome 13, are found in nearly 1%  of 
carcinoma of  breast  in women under 40 yrs  of  age. Ataxia telengectasia 
mutation and p53 Gene mutation is also found to be associated with breast cancer.  
The susceptibility to breast cancer in BRCA2 families belong to autosomal 
dominant trait and higher penetrance.BRCA2 gene associated breast cancer 
associated with invasive ductal carcinoma and usually well differentiated. Test for 
gene mutation is done for females who are at increased risk of breast cancer.  The 
test that is available is gene sequence analysis. Females belonging to the high risk 
factors may undergo mastectomy and oophorectomy  prophylactically.  Tamoxifen 
an selective estrogen receptor modulator can be used as preventive agent which is 
approved by FDA [2].  
Symptoms and Signs of Breast Cancer: 
The main complaint in almost 70% of the patients with carcinoma breast is a 
painless lump in breast. Other symptoms noted are pain in the breast; discharge 
from nipple or with erosion, retraction of nipple with itching or redness. It may 
also present as mass in axilla or edema of the arm as the first symptom. Weight 
loss, jaundice, bone pain may be rarely seen on initial presentation due to systemic 
metastases.  
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For proper inspection of the breast during physical examination, patients should be 
instructed to sit with arms by her sides and raise the arm over head. In this position 
any abnormal difference in size of the breast can be made out and even mild nipple 
retraction or dimpling of skin may be made out clearly.  
Patient can also be examined in supine or lying position.Both axilla and 
supraclavicular region should be examined for any enlargement of nodes in the 
above area. 
Carcinoma breast usually present as mass with firm to hard in consistency,not 
tender with ill defined margins. In paget’s disease nipple erosion may be the only 
presentation in patients. Serous or bloodstained discharge from the nipple may 
occur but is usually found in benign disease of breast.  
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PEAU-D-ORANGE APPEARANCE WITH NIPPLE RETRACTION IN CA 
BREAST PATIENT 
 
 
 
 
 
 
 
 
 
 
 
 
 33 
 
 
CA BREAST WITH  SKIN ULCERATION 
 
 
 
 
 
 
 
 
 
 
 34 
 
INVESTIGATIONS 
The Investigations are done to 
1) To confirm the diagnosis. 
2) To assess the extent of disease. 
3) To assess the prognostic and predictive factors. 
4) To assess the general condition of the patient. 
Diagnostic Test: 
1) FNAC: 
FNAC is a method in which by using 23 gauges needle cells are aspirated for 
cytological examination. Cellular material obtained by FNAC is expressed on to 
microscopic slideand the slide is airdried or fixed using 95% ethanol. After that 
the slides are examined microscopically .The sensitivity and specificity are nearly 
100% when a mass in the breast is evident clinically. The rate of false positive 
diagnosis is very low in case of FNAC.FNAC also yields a very high false 
negative rate.The main disadvantage of FNAC is that non invasive cancer cannot 
be differentiated from invasive carcinoma. 
2) CORE-NEEDLE BIOPSY: 
      It is a method by which core of tissue is obtained by using large cutting needle 
or by biopsy devices like tru-cut needle. Automated device are also used to obtain 
core biopsy. It is done under local anesthesia. Specimens obtained are kept in 
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formalin and examined by paraffin blocks. Core biopsy has the advantage that 
tumour markers such as estrogen receptor(ER), progesterone receptor (PR) and 
Her-2 / neu over expression can be performed on core of tissue. 
3) OPEN BIOPSY: 
        Open biopsy or excisional biopsy is done when tumor size more than 4 cm. It 
is done under local anesthesia. It should be done before a definitive treatment. 
Neddle biopsy or FNAC are less expense and complications are less, when 
compared to excisional biopsy. But when FNAC and needle biopsy are 
inconclusive excisional biopsy must be done. Excisional biopsy is done to remove 
the entire lesion, not a part of lesion [6]. 
4)  IMAGE GUIDED BIOPSY: 
    It is done to diagnose non palpable lesions. 
IMAGING TECHNIQUES: 
1) Mammography 
     Used as Screening as well as Diagnostic purpose. Mammography which is used 
conventionally delivers radiation at a dose of 0.1cGy for each study. 
Mammography which is used for screening purpose detects breast carcinoma in 
patients who are asymptomatic. It is also done in high risk patients like when there 
is a 1) Family history positive or susceptibility to genetic mutation.   Annually after 
25 years or 5-10 years prior to  age of youngest breast cancer stage in family 2) 
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Lobular crcinoma in situ or Atypical Hperplasia 3)Prior History of breast cancer 4) 
Women with lifetime risk >20% 5) Prior thoracic radiotherapy: Annually after 25 
years or 8-10 years after RT. For Normal Risk Patients screening is done yearly for 
patients above 40 years of age [7]. View by Craniocaudal (CC) and the 
mediolateral oblique (MLO) are the two important views used for screening 
mammography. The MLO view is used for imaging the outer and upper quadrant 
and axillary tail. This view will cover the maximum volume of breast tissue. For 
proper visualization of breast in the medial aspect MLO view is obtained. This 
view allows greater compression of breast than MLO view.10 
For abnormal findings such like mass in breast with nipple discharge diagnostic 
mammography are used. For exact location of the abnormality CC view is used 
along with 90 degree lateral view. Mammographic abnormality which is obscured 
by the tissues are covered above with compression device. Specific mammographic 
features which suggest breast carcinoma diagnosis of breast cancer are a) A Mass 
which is solid with presence or absence of stellate features. b) Thickening of breast 
tissue is not symmetrical c) Clustered micro calcifications.d) Suspicious lesion 
with fine stippled calcium are more in favour of breast cancer. It is an important 
sign of cancer in younger females who don’t have any other abnormality. 
Mammography is used for early breast cancer detection which provides a true 
positive rate of 90%. In Xero mammography techniques image is obtained on a 
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Xerography plate that gives mostly positive image. Digital mammography is 
developed to allow observer to manipulate the degree of contrast in the image 
which is useful in women with dense breast and women less than 50 yrs of age. 
Digital and screen film mammography had similar accuracy rate [13]. 
Breast imaging reporting and data system (BI-RADS) was deviced to standardized 
mammographic terminology which facilitates outcome monitoring and reduce 
confusing interpretations. BI-RADS uses a standardized lexicon to facilitate the 
uniformity of mammographic reports from different radiology facilities .The 
standardized mammography report also includes an overall assessment of the 
probability of malignancy that is incorporated in an impression at end of every 
mammographic report. There are six assessment categories each associated with 
the management recommendation. 
Only BI-RADS categories 1, 2 and 0 should be used for screening mammograms. 
BI-RADS category “0” - “incomplete assessment ’’- identifies cases in which 
additional images is needed before a final assessment can be need. Once the 
additional imaging is accomplished the cases assigned one of the six “final 
assessment” categories .The inclusion of final assessment in the impression of 
every mammography report eliminates equi vocation by the interpreter .The final 
assessment also facilitates the follow-up and tracking of patients, because each 
final assessment category is associated with one specific follow-up 
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recommendation. Mammography, ultrasound breast and MRI are now included in 
BI-RADS (2003) new edition [12].   
Mammography: Final assessment categories   
Category 1: Assessment is negative  
                Description and recommendation- Routine Screening is recommended. 
Category 2:  Benign finding  
                    Routine screening is recommended .This is a definitely benign finding. 
Category 3: Probably benign finding 
                    Very high probability of benignity, therefore short term followup is 
recommended to establish stability. 
Category 4: Abnormality which looks doubtful 
                    Malignancy probability is reasonable but not characteristic. Biopsy 
should be considered. 
Category 5: Malignancy is highly suggested  
                    Proper action should be taken as probability of malignancy is very 
high 
Category 6: Known Cancer. Appropriate action should be taken.  
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FIG: MAMMOGRAPHY – CRANIO-CAUDAL VIEW 
 
 
FIG:  MAMMOGRAPHY MEDIOLATERAL OBLIQUE VIEW 
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Ductography : 
Ductography are done when there is a nipple discharge which is a fluid that 
contains blood. Mammography is done after injecting a contrast media which is 
radiopaque into one of the major ducts.  
Blunt cannula of small size is inserted into the nipple ampulla after the duct is 
gently enlarged with a dilator. CC and MLO mammographic views are obtained 
after injecting 0.2ml of contrast media which is dilute. Small filling defects 
obtained after injection of contrast media is suggestive of intraductal papillomas. 
Breast carcinoma may appear as multiple intra luminal filling defects or as 
irregular masses [2].                               
ULTRASOUND 
It is the imaging modality of choice in young women with dense breasts. It is done 
to resolve equivocal mammographic findings. It defines Cyst masses and 
Demonstrate echogenic qualities of solid abnormalities. Benign  Breast mass 
appears as smooth contours with oval or round shape with echoes internally  and 
well-defined  posterior and  anterior margins.CA Breast has  walls that are 
irregular but smooth margin may  also be seen along with  acoustic enhancement. 
Ultrasound does not detect lesions less than 1 cm diameter.  
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MAGNETIC RESONANCE IMAGING 
Breast cancer when diagnosised by MRI is low in probability in conditions where 
there are negative findings in both mammography and physical examination.MRI 
is useful in Screening high risk women and contralateral breast in newly diagnosed 
breast cancer. It is more sensitive than mammogram to assess the response after 
neoadjuvant chemotherapy and plan Breast conservation surgery. It differentiates 
scarring from recurrence. It is useful in patients when axillary lymph node is 
positive for adenocarcinoma or Paget’s disease present without a primary in 
clinical examination or other imaging [12]. 
METASTATIC WORKUP 
 X-ray Chest 
 Ultra-sound Abdomen 
 CT Scan chest 
 Skeletal survey/Bone scan 
X-ray chest: 
    It is done to rule out pleural effusion, Lung involvement or erosion of Rib. 
Ultra-sound Abdomen: 
     Ultra-sound Abdomen is done to rule out involvement of liver, presence of 
Ascites, Kruckenberg  tumor and pleural effusion. 
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CT Scan chest: 
     It is done when there is doubtful lesion on X ray chest or when chest wall 
involvement suspected. CT scan can pick up internal mammary nodes, small lung, 
liver and brain metastasis.  
Skeletal survey: 
Skeletal survey includes X ray Skull AP & Lateral , X ray spine of  dorsolumbar 
and X ray  cervical spine and X ray pelvis . 
Bone scan: 
Indications  are T3, T4 lesions, when there is bone pain and Elevated Alkaline 
phosphates. 
INVESTIGATIONS FOR PROGNOSTIC/PREDICTIVE FACTORS: 
 Prognostic:  Sentinel lymph node biopsy  
 Predictive :   ER/PR status,Her2 neu status 
Sentinel Lymph Node Biopsy: 
Sentinel Lymph Node is the first node encountered by the tumour cells as they 
metastasize to the axilla. It is a representative of entire axillary basin. Biopsy of 
sentinel lymph node is indicated to know the axillary lymph node status in 
clinically negative lymph nodes with T1 or T2 primary breast cancer [20]. 
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Technique: Vital blue dye or radio-labelled colloid injected into the parenchyma 
and measured with lymphoscintigraphy with gamma camera. It provides same 
staging information with more accuracy and less morbidity.  
Indications: 
It is indicated in breast cancer in early stage without palpable nodes. When a 
previous exicisional biopsy done. And also useful in multifocal tumours confined 
to one quadrant [21]. 
Hormone Receptor levels: 
Estrogen and progesterone levels should be determined in breast carcinoma 
because these hormonal levels predict response to hormone therapy.Better 
prognosis is seen in tumors with Estrogen receptor positive tumors than tumors of 
negative estrogen receptor. Estrogen and progesterone receptor levels may be 
determined by a competitive binding assay to measure cytosol receptor levels or by 
immunohisto chemical assay where a monoclonal antibody binds to the receptor. 
Molecular markers also play a role in determining the prognosis of the breast 
cancer.HER-2neu is a transmembrane protein which is involved in regulation and 
control of cellular growth. Over expression of HER-2neu is an independent 
predictor of poor prognosis in CA breast patients. It is also a predictor of 
favourable response to chemotherapy in node positive breast cancer patients. 
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The density of neovascularization and the occurrence of cathepsin D, myc, ras and 
p53 are also measured in specimens of breast tumors. Measurements of  S phase 
fraction and the proliferation marker Ki-67 which is used to estimate the growth 
rate of malignant tumors.DNA content of tumor cells measured by flow cytometry 
also correlates with prognosis [16].  
 STAGING OF BREAST CANCER: 
Staging place an integral role in the management of breast cancer .Breast cancer 
staging is used to determine the extent of the disease, predict survival overall and 
provide guidance for therapy. Epidemiologists and public health researches rely on 
breast cancer staging methods to evaluate trends in breast cancer incidence, 
screening programs, treatment outcomes and risk factors worldwide. Staging also 
place an integral part in advances in breast cancer research and in the application of 
basic science to clinical science [15]. 
Evolution of staging system: 
Early staging systems for breast cancer were based on feasibility of operative 
intervention. Tumors where classified as either operable or inoperable. In 1905 
German Physician Steinthal recommended three different classifications for breast 
cancer. This classification was based on clinical factors that were considered as 
important in predicting prognosis. Primary Tumor size was included in this 
primitive staging scheme. In 1928 Lee and Stubenbord included an index of the 
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rate of tumor growth in the staging scheme. This method was the first to attempt 
assessment of biology of individual tumors and their potential for progression.    In 
1940 four stage MANCHESTER classification was introduced it  permitted staging 
based on clinical criteria, the extent of local involvement by the primary tumor, the  
presence  of  mobile axillary lymph node which is palpable and metastasis in 
distant organ. Disadvantage of this classification is it neither includes pathologic 
information nor tumor size. 
Manchester System 
Stage I: 
    The tumor is confined to the breast. Involvement of the skin may be present, 
provided the area is small in relation to the size of the breast 
Stage II: 
The tumor does not extend beyond breast and presence of  lymph nodes in the 
axilla. 
 Stage III: 
Tumor extension beyond the breast is demonstrated by the following: 
a) Invasion, fixation or ulceration of skin of a large area in relation to the size of 
the breast.  
b) Fixity of tumor to deeper structures like muscle, fascia and presence of mobile 
axillary nodes. 
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Stage IV: 
The tumor extension beyond the breast is characterized by the following 
a) Fixation or matting of the axillary nodes 
b) Fixity of tumor to chest wall 
c) Presence of metastasis in supraclavicular nodes or in the contralateral breast 
d) Satellite nodules or distant metastases 
In 1943 PORTMANN described a staging system that included clinical, pathologic 
and radiographic characteristic of breast cancer .This classification included skin 
involvement,the location and mobility of the primary tumor and extent of local and 
distant metastases. 
Portmann Classification 
Stage I: 
Skin- not involved 
Tumor-localized to breast, mobile 
Metastases-none 
Stage II: 
Absence of skin involvement. 
Tumor-confined to breast, mobile 
Presence of Metastasis in axillary node evaluated by microscopic examination. 
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Stage III: 
Edema of skin, brawny red induration and inflammation which is not caused by 
infection, extensive ulceration, multiple secondary nodules. 
Diffuse infiltration of breast with tumor, fixity of tumor to chest wall, Breast 
edema and secondary tumors. 
Metastasis in axillary lymph node which is fixed with absence of distant metastasis 
clinically or roentgenologically.  
Stage IV: 
Skin-involved or not involved 
Tumor-localized or diffuse 
Metastasis in both axillary and supraclavicular lymph nodes with presence of 
distant metastasis clinically or roentgenologic evidence of more distant metastases.  
Columbia Clinical Classification : 
Stage A: 
Absence of involvement of skin, fixation of tumor to chest wall or non palpable 
axillary node. 
Stage B: 
Absence of either involvement of skin or fixity of tumor to chest wall with axillary 
node palpable not more than 2.5 cm and mobile. 
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Stage C: 
Signs of advanced breast carcinoma which are considered as grave are: 
1) Edema of skin not involving more than one third of skin overlying the breast 
2) Ulceration of skin 
3) Fixity of tumor to chest wall 
4) Presence of involvement of axillary node more than 2.5 cm in size.  
5) Axillary nodes fixed to skin or underlying structures. 
Stage D: 
Signs of advanced breast carcinoma includes: 
1) Out of five grave signs any two signs should be present as given in stage C.          
2)  Involvement of skin more than one third of skin which overlies the breast.   
3)  Satellite skin nodules 
4) Carcinoma of inflammatory type 
5) Presence of supraclavicular node involvement.  
6) Metastasis in internal mammary node by presence of parasternal tumour 
7) Involvement of edema of arm 
8) Metastases in distant organ 
Columbia clinical classification: 
Four stages were defined .Staging included physical examination and 
roentgenographic information.Tumor size and pathologic data was not included in 
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this staging. Based on five “grave signs “  staging was done.It includes 1)skin 
edema of  Breast skin 2) skin overlying breast ulcerated 3)fixity of tumor to chest 
wall 4) fixity of node to skin or deep tissue  5)node of axillary group more than 
2.5cm. Stage A and B were considered as operable cancers.Stage C were 
considered as locally advanced cancer.Stage D tumors were considered as 
inoperable tumors.  
TNM SYSTEM: 
Pierre Denoix introduced TNM System in 1940 which represented to classify 
cancer based on morphologic patterns of malignant tumors which influenced 
prognosis such as size of the primary tumor (T), presence and extent of regional 
lymph node involvement (N), and presence of distant metastases (M). 
TNM System was originally conceived to be a simple system that would classify 
patients into various groups each with the different survival rate and prognosis. 
Currently the most popular staging system is the TNM System based on AJCC 
sponsored by the American college of society and American college of surgeons. 
Staging system currently requires confirmation by microscopy and typing of tumor 
by histology before doing any stage classification. Any patient with documented 
breast cancer may then be staged by clinical or pathological criteria (Designated by 
“c” prefix or “p” prefix).Diagnostic staging requires complete clinical examination 
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with assessment of same side or opposite side neoplastic involvement of skin, 
breast tissue, muscle and lymph nodes.              
The microscopic diagnosis of breast cancer must be confirmed by examination of 
breast tissue. Routine laboratory examinations, chest X-ray and bilateral 
mammograms are also recommended. 
Specific Stages: 
T Stage (Tumor Size) : 
Clinical tumors stage is the size of the tumor reported in centimeters based on 
physical examination and various imaging modalities. The pathologic T stage is 
based on tumor size on the final pathologic specimen measuring only the invasive 
component. 
N Stage: 
Staging of clinical node depends on physiological and radiological examination 
which includes CT and ultrasound and not including lymphoseintigraphy. 
Metastases to ipsilateral supraclavicular lymph node disease were considered to 
have prognosis similar to that for patients with distant disease. 
Staging of lymph node pathologically depends on biopsy of sentinel lymph node or 
dissection of axillary node completely. 
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M Stage: 
Metastasis in distant organs is M1 disease. Supraclavicular lymph node diseases on 
same side is not considered as distant metastasis, but included in locally advanced 
disease. Metastatic disease is evidenced by physical examination and clinical 
history. Imaging modalities may or may not be included. 
AJCC primary tumor (T) classification for breast cancer: 
TX : Assessment  of  Primary tumor cannot be done 
T0  : No evidence of  primary tumor 
Tis  : Carcinoma in situ 
Tis(DCIS):   Ductal carcinoma in situ 
Tis(LCIS)  :  Lobular carcinoma in situ 
Tis( Paget’s) : Paget’s disease of the nipple Not associated with invasive 
carcinoma  and/or carcinoma in situ (DCIS and/or LCIS)  in the underlying breast 
parenchyma.Carcinomas in parenchyma of  breast  associated with Paget’s disease 
are categorized based on the size and characteristics of  the parenchymal disease.  
T4: Direct extension of tumor to skin or chest wall. Tumor can be of any size. 
Note: Skin involvement alone cannot be considered as T4.  
T4a: Tumor extending to chest wall but invasion of pectoralis muscle not included.  
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T4b: Edema (including peau d’orange) or Ulceration of skin or satellite nodules 
ipsilaterally which are not the criteria for inflammatory carcinoma. 
T4c: Both T4a and T4b 
T4 d: Inflammatory carcinoma 
TNM- Nodal Status, Clinical: 
Nx:  Assessment of Regional Lymph nodes cannot be done.  
No: No metastasis in regional lymph node 
N1:  Metastases in axillary node level I and II of same side which is mobile 
TNM- Nodal Status, Clinical: 
N2:   N2a: Axillary node level I and II on same side matted to each other or with 
adjacent structure.                   
N2b: Absence of axillary node involvement in presence of clinically palpable same 
side internal mammary node.          
Nodal Status- Pathological: 
pNx: Assessment of Regional lymph nodes cannot be done.(e.g.,Nodes when 
removed  previously for pathologic study) 
pN0: No regional lymph node metastasis histologically 
Note: Small clusters of cells not more than 0.2 mm are known as isolated tumor 
cell clusters. It also includes single tumor cells, or a cluster of fewer than 200 cells 
in a single histologic cross-section. ITCs may be detected by routine histology or 
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by immunohistochemical(IHC) methods. ITCs containing nodes are not included 
in the total positive node count for purpose of N classification but should be 
included in the total number of nodes evaluated. 
pN0(i-) : No regional lymph node metastasis histologically,negative IHC. 
pN0(l+) : Regional lymph node contains Malignant cells in not more than 0.2 
mm(detected by H&E or IHC including ITC) 
pN0(mol-) : No metastases in regional  lymph node            
pN0 (mol +):  Positive molecular findings (RT-PCR), but no metastasis in 
regional lymph nodes detected by histology or IHC 
Classification is based on whether axillary lymph node dissection done or not 
pN1:  Micrometastases or metastases in 1-3 axilliary lymph nodes  and /or in 
internal mammary nodes with metastases detected by sentinel lymph node biopsy 
but not clinically detected 
pN1mi: Micrometastases(greater than 0.2 mm and/or more than 200 cells but 
none greater than 2.0mm) 
pN1a: Metastases in 1-3 axilliary lymph nodes, at least one metastasis greater 
than 2.0mm 
pN1 b: Metastases in internal mammary nodes with micrometastases or 
macrometastases detected by sentinel lymph node biopsy but not clinically 
detected 
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pN1 c: Metastases in internal mammary lymph nodes which are detected on 
clinical examination in the absence of axillary lymph node  or  presence  of 
metastases in axillary lymph nodes of 1-3 . 
pN2: Metastases in 1-3 axillary lymph nodes or in clinically detected internal 
mammary lymph nodes in the absence of axillary lymph node metastases. 
pN2 a: Axillary lymph node metastasis in 4-9 nodes. One tumor deposit should be 
more than 0.2 mm.  
pN2b : Internal mammary lymph node metastasis detected clinically with absence 
of metastasis in axillary lymph node. 
pN3 : Metastases in axillary lymph nodes in ten or more or infraclavicular (level 
III  axillary) lymph node metastasis or same side internal mammary node detected 
clinically. In presence of one or more axillary lymph node involvement or more 
than three axillary lymph node with sentinel lymph node detected micro or macro 
metastasis.  
pN3 a: Metastases in ten or more axillary lymph nodes (at least one tumor deposit 
greater than 2.0mm) or metastases to the infraclavicular (level III axillary lymph) 
nodes 
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pN3 b: Axillary lymph node metastasis in more than ten nodes. Deposit in one 
tumor more than 2mm or involvement of infraclavicular node. 
 pN3c: Supraclavicular lymph nodes metastasis on same side.  
TNM-Metastasis: 
Distant Metastasis (M) 
M0: Distant metastases not evident by clinical or radiological.  
cM0(l+): Absence of distant metastasis by clinical or radiographic evidence but 
tumor cells shows deposits microscopically in blood or bone marrow or 
involvement of nodes that are not regional lymph node and should not be more 
than 0.2 mm.  
M1: Distant detectable metastases are determined by classic clinical and 
radiographic means and/or histologically proven larger than 0.2 mm 
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STAGING: 
Stage 0 Tis N0 M0 
Stage IA T1 N0 M0 
Stage IB T0 N1 M0 
 T1 N1 M0 
Stage II A T0 N1 M0 
 T1 N1 M0 
 T2 N0 M0 
Stage II B T2 N1 M0 
 T3 N0 M0 
Stage III A T0 N2 M0 
 T1 N2 M0 
 T2 N2 M0 
 T3 N1 M0 
 T3 N2 M0 
Stage III B T4 N0 M0 
 T4 N1 M0 
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 T4 N2 M0 
Stage III C Any T N3 M0 
Stage IV Any T Any N M1 
 
 
There  are  five stage  grouping ( 0,I,II,III AND IV) in the new  TNM staging 
system. Stage 0 refers to preinvasive cancers that are (carcinoma in situ) which 
means the tumor has not penetrated the basement membrane of the lobule or duct. 
These tumors have an excellent prognosis as there are no regional or distant 
metastases in this stage. Tumor belonging to Stage I are micrometastatic. 
Stage II A and Stage II B include tumors with regional lymph node metastases and 
therefore carry a worse prognosis. Stage III A , Stage III B and Stage III C includes  
tumors that are  locally advanced hence  these tumors also have a worse prognosis. 
Stage IV refers to distant systemic spread of the disease which also has a worst 
prognosis.   
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Histologic Grade 
GX Assessment of Grade cannot be done. 
G1 Low combined histologicgrade 
(favourable) 
G2 Intermediate combined 
histologicgrade(moderate favourable) 
G3                                                                                                      High combined histologic grade  
(unfavourable) 
This grading is based on Nottingham combined histologic grade. The grade G of 
the tumor is designated based on the morphologic features of primary tumor which 
includes mitotic count, pleomorphism of nuclei and formation of tubule. 
Overview of Breast Cancer: 
Insitu Breast Cancer (Stage 0)- Both DCIS AND LCIS are indistinguishable from 
atypical hyperplasia or from early invasion of cancers. Mammography on both 
sides is done to find the extent of insitu carcinoma or a second cancer. Treatment 
options for LCIS are either observation, chemoprevention with tamoxifen and 
bilateral total mastectomy. This is for prevention or detection of the invasive 
cancer at an earlier stage as there is 25 to 35% risk of LCIS developing into 
invasive cancer. 
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 Low grade DCIS which includes papillary, cribriform or solid which is not more 
than 0.5 cm in diameter can be managed by removal of lump alone, without 
radiation if margins resected are free of disease. DCIS that are not palpable are 
surgically resected under the guidance of localized needle technique. 
Women with DCIS treated with mastectomy have recurrence locally and mortality 
rates less than 2%.When managed with removal of lump and adjuvant radio 
therapy recurrence rate is 9%.      
Early Invasive Breast Cancer (Stage I, IIA or IIB): 
Mastectomy with assessment of axillary lymph node status and breast conserving 
therapy are considered for patients with Stage I and II breast cancer. Axillary node 
dissection is considered when there is axillary lymph node shows metastatic 
disease. Breastconservation therapy is not indicated in multicentric disease, 
previous radiotherapy to either chest wall or breast, surgical margins involved and 
scleroderma. 
Level I and II axillary nodes dissection are done in early invasive breast cancer. 
Sentinal lymph node dissection is done to evaluate the status of axillary lymph 
node in patients who have clinically negative lymph nodes. 
Adjuvant chemotherapy is given for patients with node positive tumors or with 
patient tumor size more than one cm and patient with node negative cancer more 
than 0.5 cm. Tamoxifen therapy is given for patients with positive hormone 
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receptor cancers that are more than 1cm.Trastuzumab is the only HER/2neu 
targeted agent and can be used in metastatic and adjuvant setting. It is used for 
treatment of HER-2/neu, node positive tumor [22]. 
Advanced Local-Regional Breast Cancer (Stage III A or III B): 
Stage III A OR III B are locally advanced breast carcinoma with absence of 
distant metastasis by clinical examination. Surgery is combined with 
radiationtherapy and chemotherapy for treatment of this tumor in order to provide 
local regional disease free survival. In some patient with Stage IIIA cancer 
downstaging of the tumor can be done by neoadjuvant chemotherapy and allow 
breast conserving surgery [2]. Ipsilateral breast tumor recurrence rate are more in 
patients with clinical N2 or N3 disease. In both Stage IIIA and III B disease 
surgery is followed by adjuvant radiationtherapy. 
Distant Metastases (Stage IV): 
Stage IV breast cancer cannot be cured by treatment but survival rate may be 
increased. Hormonal therapies are more preferred than cytotoxic chemotherapy 
because of minimal toxicity. Females with positive hormone receptor cancers are 
treated by hormonal therapy. Metastases to bone and soft tissue also treated by 
hormonal therapy. 
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Chemotherapy is given systemically for patients with hormone receptor negative 
cancers and metastatic cancer refractory to hormonal therapy.   
Bisphosphonates may be given with chemo or hormonal therapy in women with 
bone metastases. 
Local-Regional Recurrence: 
Local-Regional breast cancer recurrence are divided into two groups those who 
have underwent mastectomy and those who underwent removal of lump. Women 
who have been treated previously with mastectomy undergo surgical resection of 
local recurrence with suitable reconstruction. Chemo and antiestrogen therapy is 
given if no radiotherapy is given to chest wall. Women who underwent 
lumpectomy should again undergo mastectomy with suitable reconstruction. 
The 5 yr survival rate for patient with Stage I diseases 94%, Stage II A 85%, Stage 
IIB 70% ,Stage III A and IIIB 52 and 48% respectively. Stage IV tumor 18%. 
Survival rate in breast cancer has significantly increased in the last two decades 
due to improvement in screening and local and systemic therapies. 
Early detection of Breast Cancer: 
A.Screening Programmes: 
Screening program includes both mammographic and physical examination of 
female patients who are without symptoms identify about ten cancers per thousand 
above the age of 50 and about two cancer per thousand in females below age of 
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50.For maximum result in screening programs, mammographic and physical 
examination are necessary. Breast cancers at earlier stage can be found only by 
mammography in about 35-50% and by palpation another 40% can be found. 
Abnormalities that are found by screening mammogram is malignant when biopsy 
is performed..Women aged 20-40 yrs should examine her breast regularly and 
routinely every 2-3 years. Annual breast examination must be done in females 
above 40 years [7].  
The sensitivity of mammography varies from 60-90% which depends upon 
different factors including age of patient, tumor size, appearance and location of 
tumor by mammography. Mammography is more sensitive in older women than 
young females with dense breast and can detect malignancies up to 90 %.Tumors 
with absence of calcification and small in size is less likely to be detected in 
females with dense breast [10]. 
For non palpable abnormalities the rate of specificity of mammography is 30-40% 
for females below age 50 years and for clinically evident it is 85-90%.There is no 
doubt about beneficial effect in females aged 50-60 yrs who undergo screening and 
all clinical trials have confirmed it. The benefit of screening in women above 70 
yrs is not conclusive. 
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B. Self-Examination: 
There is no improvement in survival rate by self breast examination. The cancer 
society of America does not recommend monthly self breast examination at 20 yrs 
age. It recommends that patient should be made aware of BSE and about its benefit 
harm and its limits. The correct technique of performing BSE should be taught to 
women. 
Patient who are in Premenopausal age group should do breast self examination 
should be done after eighth day of menstrual period. It should be done infront of a 
mirror with hands by side or above the head or press firmly on hips which 
contracts the muscle pectoralis  causing dimpling or lump to become more 
prominent . Breast can also examined in supine position by palpation with opposite 
hand. 
C. IMAGING: 
Before a lump can be detected, Mammography is the most reliable method of 
detecting a breast cancer .Slow growing cancers can be detected by mammography 
atleast two years before reaching a size identified by palpation. Less than 0.4 cGy 
is delivered by flim screen mammography to midpoint of breast per view. 
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Digital mammography allows an easier method to maintain and review 
mammogram but it does not provide better images nor increased detection rates 
more than film mammography [7, 10]. 
 Digital mammography are better in women with dense breast. Calcifications are 
more easily recognized mammographic abnormality.  
Most common findings are clustered polymorphic microcalcifications  which are 
atleast 5-8 in numbers and aggregrated in one part of the breast and differs from 
one another in shape and size mostly branched are VorY configuration. 
Indications for mammography are a) To Screen females who are without 
symptoms and high risk for developing breast cancer at regular intervals b) 
Evaluation by Regular interval once in a year in each breast which as breast cancer 
that is potentially cureable. c) For evaluation of breast mass not well defined or 
suspicious lesion in breast d) to search in patients with axillary node metastasis in 
absence of primary tumor or primary not found. 
 e) For monitoring female with breast carcinoma treated already by radio therapy 
and surgery. f) For detection of opposite side breast in a postmastectomy patients.  
Biopsy should be done inspite of mammography in patients with doubtful mass. 
Before biopsy mammography should be done so that areas which are doubtful can 
be identified and opposite breast can be evaluated.  
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Mammography is not an alternative for biopy as it does not show clinical cancer in 
breast which is very dense  as seen in young women with fibrocystic changes and 
may not reveal medullary cancers. 
For screening in women who are at increased risk of carcinoma of breast, MRI and 
Ultrasound may be used. The sensitivity of MRI  is much higher than 
mammography but specificity is lower.MRI is useful in women with breast 
inplants to determine the character of a lesion present in the breast and to search 
for inplant rupture. 
 It is also helpful in patients who underwent lumpectomy and radiation. Positron 
Emission tomography may play a role in imaging atypical lesions but are less 
sensitive for early breast cancer.It is used mainly for evaluation of metastatic 
deposits.  
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MATERIALS AND METHODS 
This study was carried out in 150 patients who were admitted in the department of 
general surgery, Government Rajaji Hospital, Madurai during the period from 
January 2011 to December 2012. 
This Study which was undertaken was a prospective case series study and was 
started after getting due clearance from the institute of ethical committee, 
Government Rajaji Hospital, Madurai Medical College. Patients were included in 
this study after getting their informed written consent and they were assured that 
information obtained from them will be kept confidential. 
Inclusion Criteria for patients in this study consist of patient of any age presenting 
with the lesion suspected of breast carcinoma and proved by FNAC and TRU-CUT 
biopsy and all relevant investigations to stage the disease like chest X-ray, 
ultrasound abdomen, liver function test, mammography and skeletal survey done 
for advanced cases to rule out metastasis.   
Patients excluded where those who presented with symptoms of breast on clinical 
examination but on investigation there was no malignant pathology of breast and 
male patients with breast carcinoma excluded. 
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Patients data was collected in standardised proforma which included age, socio 
economic status, level of education, duration of symptoms, detection of lump  by 
the patient or medical practitioner, into three  class lower, middle and upper any 
previous visit to local doctor for this illness, any prior investigations performed and 
stage of tumor at time of presentation.  
Socio economic status defined by kuppusamy scale was used in this study which 
was based on three major variables contributing to socio economic status which 
included education, occupation and income. Based on these three variables score 
given and socio economic status classified into five class. 
 Score of 26-29-upper class 
 Score 16-25-upper middle 
 Score of 11-15 as lower middle 
 Score of 5-10 as upper lower  
 Less than 5- lower class. 
In this study upper middle and lower middle combined as middle class and upper 
lower and lower combined as lower class. Hence in this study socioeconomic 
status classified into three class lower, middle and upper. 
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Literacy status classified into illiterate and educated which is further classified into 
primary (I-IV), secondary (High School and Higher Secondary) and higher 
education (Graduate and above). 
 People belonging to higher socio economic status or with higher education were 
not admitted in our hospital during the period of this study.  
Definition for stage at diagnosis was based on classification for clinical staging of 
breast cancer outlined in American joint committee on cancer staging. Patients data 
collected were analyzed statistically. 
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OBSERVATION AND RESULTS 
                          The findings of the study can be tabulated as follows. 
 
AGE DISTRIBUTION IN THE STUDY 
Age in years Stage I Stage II Stage III Stage IV 
20-30 - 1 1 - 
30-40 2 9 5 - 
40-50 2 20 29 2 
50-60 - 16 32 4 
60-70 - 1 16 2 
70-80 - - 7 1 
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AGE DISTRIBUTION IN THE STUDY 
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DISTRIBUTION OF STAGE OF TUMOR BASED ON SOCIO ECONOMIC 
STATUS OF PATIENT 
Stage of the 
tumor 
Lower Class Middle Class Upper Class 
I 1 3 - 
II 42 5 - 
III 88 2 - 
IV 9 - - 
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DISTRIBUTION OF STAGE OF TUMOR BASED ON LITERACY STATUS 
OF PATIENTS 
Stage of 
tumor 
Illiterate Primary Secondary Higher 
Education 
I 1 2 1 - 
II 13 28 6 - 
III 70 17 3 - 
IV 8 1 - - 
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DISTRIBUTION OF STAGE OF TUMOR BASED ON SOCIO ECONOMIC 
STATUS OF PATIENT 
 
 
DISTRIBUTION OF STAGE OF TUMOR BASED ON LITERACY STATUS 
OF PATIENTS 
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DISTRIBUTION OF STAGE OF TUMOR BASED ON DURATION OF 
ILLNESS 
Stage of 
tumor 
< 3 mon 3-6 mon 6-12 mon >12 mon  
I 4 - - - 
II 12 32 3 - 
III - 1 68 21 
IV - - 3 6 
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DISTRIBUTION OF DURATION OF ILLNESS ACCORDING TO 
LITERACY STATUS OF PATIENTS. 
Literacy < 3 mon 3-6 mon 6-12 mon > 12 mon 
Illiterate 2 12 55 23 
Primary 10 20 13 5 
Secondary 4 3 3 - 
Higher 
Education 
- - - - 
 
 
DISTRIBUTION OF DURATION OF ILLNESS ACCORDING TO SOCIO 
ECONOMIC STATUS OF PATIENTS. 
Socio 
Economic 
Status 
< 3 mon 3-6 mon 6-12 mon >12 mon 
Lower  11 30 71 28 
Middle 5 4 1 - 
Higher - - - - 
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DISTRIBUTION OF STAGE OF TUMOR BASED ON DURATION OF 
ILLNESS 
 
DISTRIBUTION OF DURATION OF ILLNESS ACCORDING TO 
LITERACY STATUS OF PATIENTS. 
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DISTRIBUTION OF STAGE OF TUMOR ACCORDING TO DURATION 
OF SYMPTOMS IN ILLITERATE PATIENTS 
Stage of 
tumor 
< 3 mon 3-6 mon 6-12 mon > 12 mon 
I 1 - - - 
II 1 10 2 - 
III - 2 50 18 
IV - - 3 5 
  
DISTRIBUTION OF STAGE OF TUMOR AND DURATION OF ILLNESS 
IN PATIENTS WITH PRIMARY EDUCATION 
Stage of 
Tumor 
< 3 mon 3-6 mon 6-12 mon > 12 mon 
I 2 - - - 
II 8 20 - - 
III - - 13 4 
IV - - - 1 
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DISTRIBUTION OF STAGE OF TUMOR AND DURATION OF ILLNESS 
IN PATIENTS WITH SECONDARY EDUCATION 
Stage of 
Tumor 
< 3 mon 3-6 mon 6-12 mon > 12 mon 
I 1 - - - 
II 3 3 - - 
III - - 3 - 
IV - - - - 
 
DISTRIBUTION OF STAGE OF TUMOR AND DURATION OF ILLNESS 
IN LOW SOCIO- ECONOMIC CLASS OF PATIENTS 
Stage of 
Tumor 
< 3 mon 3-6 mon 6-12 mon > 12 mon 
I 1 - - - 
II 10 29 3 - 
III - 1 65 22 
IV - - 3 6 
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DISTRIBUTION OF STAGE OF TUMOR AND DURATION OF 
SYMPTOMS IN MIDDLE CLASS PATIENTS 
Stage of 
Tumor 
< 3 mon 3-6 mon 6-12 mon > 12 mon 
I 3 - - - 
II 2 3 - - 
III - 1 1 - 
IV - - - - 
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DISCUSSION 
In our study 150 patients with breast cancer were studied over a period of two 
years from January 2011 to December 2012. Ca breast was found to be more 
common among females in the age group of 40-60 yrs (70%).  
This compares favorably with studies done by Bibb and Sandha [46] in which 
maximum number of cases among African women and white women were around 
the age of 48yrs and 59 years respectively. 
Out of 150 patients admitted, 4 patients  (2.7%) presented in Stage I, 47 patients 
(31.3%)  in Stage II, 90 patients (60 %) were in Stage III and 9 (6%) were in Stage 
IV. These results were not too dissimilar from a study done by Faisal Bilal 
Lodhi[55]  where 25% of patients presented in Stages I & II. 62.7% were in Stage 
III and 12% were in Stage IV. 
Out of 150 patients 92 patients (61.3%) were illiterate,48(32%) were educated upto 
primary level,10 patients(6.7%) with secondary education.Out of 150 patients ,140 
patients (93.3%) belonged  to low socio economic status and 10 patients(6.7%) 
belonged to middle class.According to educational status out of 92 illiterate 
patients only one patient presented in stage I,13 patients(14.1%) presented in stage 
II ,70 patients (76.1%) in Stage III and 8 patients(8.7%) in Stage IV. out of 48 
patients who were educated upto primary level only 2 patients(4.2%) presented in 
Stage I  and 28 patients(58.3 %) presented in Stage II,17 patients(35.4%) presented 
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in Stage III and 1 patient(2.1%) presented in Stage IV. This is quite different from  
a study done by O’malley et al [56]  where 30% of women with a low education 
presented with late stage disease. 
Out of 140 patients belonging to a lower socio economic status only one patient 
presented in Stage I ,42 patients( 30%) in Stage II 88 patients(62.9%) in Stage III 
,9 patients(6.4%) in Stage IV. Out of 10 patients who belonged to middle class, 3 
patients (30%) presented in Stage I, 5 patients (50%) in Stage II, 2 patients(20%) 
in Stage III. These results are dissimilar from a study done by Wanq ce where 
25.4% of people from a low socioeconomic status presented in Stage III and Stage 
IV whereas 20.4% of people from a high socioeconomic status presented in a late 
Stage.  
Out of 150 patients only 49 patients presented to hospital for treatment before 6 
months of initiation of symptoms and the remaining 101 patients came to hospital 
for first visit only after 6 months of appearance of initial symptoms. Among 49 
patients who presented before 6 months of symptoms, 4 patients were in Stage I, 
44 patients in Stage II and 1 patient in Stage I. Among illiterate group 14 patients 
came for 1st visit before 6 months of initiation of symptoms 12 patients were in 
early Stage and 3 patients in late Stage of Cancer and 78 patients presented after 6 
months of initiation of symptoms out of which 2 patients were in Stage II, 68 
patients in Stage III and 8 patients in Stage IV. 
 82 
 
Among patients who were educated upto primary level 30 patients came to hospital 
for 1st visit before 6 months from imitation of symptoms out of which 2 patients in 
Stage I  and 28 patients in Stage II.18 patients came after 6 months of initiation of 
symptoms out of which 17 patients in Stage III and 1 patient in Stage IV. 
Among patients who were educated upto secondary level 7 patients came to 
hospital before 6 months from initiation of symptoms, Out of which 1 patient in 
Stage I and 6 patients in Stage II .Only 3 patients came after 6 months of initiation 
of symptoms and were found to be in Stage III. 
 Out of 140 patients belonging to lower socio economic status 41 patients(29.3%) 
came to hospital for 1st visit before 6 months from appearance of 
symptoms.Among those 41 patients ,1 patient (2.4%)was found in Stage I,39 
patients(95.1%) in Stage II and 1 (2.4%)patient in stage III.99 patients (70.7%) 
came after 6 months from apperance of symptoms out of which 3 patients (3.1%)in 
Stage II,87 patients(87.9%) in Stage III and 9 patients(9.1%) in Stage IV. 
The results were more or less similar to the study done by Faisal Bilal Lodhi [55] 
who found that 64% of patients came after 6 months of symptom and out of it 
60%found to be in advanced stage and only 4% in stage II. 
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Among 10 patients who were belonging to middle class,8 patients presented to 
hospital before 6 months from initiation of symptoms out of which 3 were found in 
Stage I,5 patients in Stage II and 1 patient in Stage III and only 1 patient came after 
6 months of initiation of symptoms and was found to be Stage III. 
Among 150 patients about 5 patients came with prior investigations which 
included FNAC and biopsy and they all belong to middle class and were educated. 
Among 150 patients lump was detected by the patient itself by 148 patients and 2 
were detected by a Medical Practitioner. 
Out of 150 patients 51 patients ( 34%) presented in early stage of cancer and 99 
patients(66%) presented in late stage of cancer.14 illiterate patients (15.2%) ,30 
patients (62.5%) of primary education  and 7 patients(70%) of secondary education  
presented in early stage and remaining 99 patients(66%) presented in advanced 
stage of cancer and  among them 78 patients(84.8%) were illiterate,18 patients of 
primary education and 3 patients of secondarily educated  presented in late stage of 
cancer. In 150 patients,43 patients (37%) of low socio economic status and 8 
patients of middle class presented in early stage(Stage I and II) and the remaining 
97 patients(69.3%) of low socio economic status and 2 patients belonging to 
middle class presented in late stage of cancer(Stage III and IV) . 
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Out of 150 patients only 49 patients presented to hospital before 6 months from 
initiation of symptoms. Patients who presented before 6 months were mostly found 
in early stage(Stage I and II) and patients presenting after 6 months of initiation of 
symptom were found to be in late stage (Stage III and IV).Patients delay in 
presentation was more in low socio economic patient and illiterate group and 
majority of this group presented in late stage of cancer. Therefore patients delay in 
presentation plays a major role in determining the stage of the tumor.  
Patients delay in presentation is more in illiterate and low socioeconomic status 
than in educated and middle class due to lack of awareness, negligence and 
financial resources. This delay in presentation adversely influence the stage of  
diagnosis. 
Impact of social inequality in cancer is not being given adeqate attention in this 
country. Lower and middle income group constitutes majority of population in our 
country. Hence socioeconomic study of cancer is important for preventive 
measures and therapeutic action plans. 
Many studies on socioeconomic variation in western countries observed late stage 
presentation of cancer and decreased survival among poor population. Reasons are 
mostly due to lack of health insurance, lack of access to health care and lack of 
information about detection of cancer and treatment. 
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This study clearly display the necessity of early medical attention to symptoms of 
breast cancer by creating awareness about detection of breast cancer at earlier stage 
and there by improve the survival rate of patients with breast carcinoma. 
Review of other Studies: 
Studies have reported that likelihood  of breast cancer survival can be influenced 
by socio economic and demographic factors such as income status(Boyd et 
al,1999,Thomson et al,2001) [39] and economically deprived(Macleod et 
al,2000)[48].  
Women of low socio economic status with breast cancer have poor out comes than 
high socio economic status women. (Thomson et al 2001) [39]. Socio economic 
factors were considered as independent prognostic factors for the stage at diagnosis 
(Gentile-brevet et al 2008) [50]. 
Survival is affected by increased duration of symptoms among breast cancer 
patients (ARNDT et al 2003) [33]. Detecting new breast cancers in its earliest 
stages increases the probability of long term survival that is why early detection of 
disease is of utmost importance (HARVAHAN et al 2007) [51]. 
Low level of female literacy is often associated with poor access to health facilities 
and poor health awareness (kuman et al 1997). 
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 women with low income were more likely to wait for a longer period of time 
following the onset of breast cancer symptoms before seeking medical treatment 
due to financial problem (Rabia ali et al 2008) [54]. 
In another study performed in 2003 it was found that patients who residing in low 
income neighbourhoods were significantly more likely to present in stage III or IV 
in comparison to patients who lived in neighbourhoods of higher income (33% vs 
24% O’malley, Legloser, Shema and Cuest) [56].  
Additionally O’malley et al 2003 found that women presenting with later stage 
disease were more likely to lie in low education (30%) and blue-collar 
neighbourhoods (29%) [56]. 
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CONCLUSION 
In our study among 150 patients 34% presented in early stage and 66% presented 
in late stage. Among the patients who presented in early stage : 
 15.2%belonged to Illiterate  
 62.5% belonged to patients educated upto primary level  
 70% of patients educated upto secondary level.  
In remaining 66% who presented in advanced stage of cancer : 
 84.8%were Illiterate,  
 37.5% were primarily educated  
 30%were secondarily educated.  
In 150 patients,30.7% of low socioeconomic status and 80% of Patients belonging 
to middle class presented in early stage(stage I  and II)and remaining 69.3% of  
low socioeconomic status and 20%belonging to middle class presented in late stage 
(stage III and IV). 
Patient  of about 32.7% who presented before 6 months of initiation of symptom 
were found in early stage I and IIand patients of about 67.3% who presented after 6 
months of initiation of symptom were found in late stage(stage III and IV).  
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About 62.5% of  patients with primary education,70% of secondary education and 
13.4% of illiterate patient presented before 6 months and were found in early stage 
I and II. and remaining 84.7% of illiterate,37.5% of primary education and 30% of 
secondary education presented after 6 months and found to be in stage III and IV.  
Only 29.2% of low socioeconomic status but 90% of middle class presented before 
6 months and were found in stage I and II. Remaining 70% of low socioeconomic 
status and 10% of middle class presented after 6 months of initiation of symptom 
were found in stage III and IV. 
In Our Study Patients who were educated upto primary and secondary level with 
middle income presented in early stage of breast cancer than patients who were 
illiterate with low socioeconomic status. 
Majority of the patients belonging to low socioeconomic and illiterate group 
presented in advanced stage of breast cancer due to patient’s negligence and lack 
of awareness about breast cancer. 
Delayed presentation of female breast cancer has a strong and significant 
attribution to patient delay which will definitely have a worse impact on stage of 
breast cancer. 
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RECOMMENDATION: 
Lower income group does not have adequate financial access to health care 
delivery system and also due to fear of loss of daily wages they neglect the 
symptoms and present to hospital only if the disease has become detrimental to her 
life. 
Also in our country breast is considered to be a sexual identity for female and most 
of female patients hesitate to disclose to their family members and feel shy or 
embraced to consult a doctor. In addition to socioeconomic factors sociocultural 
factors also play an important barrier to early diagnosis of ca breast. 
Hence targeted plans to increase breast cancer screening and treatment coverage in 
patients with lower socio economic status could reduce much of socio economic 
disparity in breast cancer diagnosis and treatment.  
National health care programmes should be launched for public awareness and 
early detection of breast cancer by screening mammography in all above age of 40 
yrs, and importance of regular self breast examination which can detect the lesion 
earlier which will provide a better survival and reduction in mortality rates due to 
breast cancer.  
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PROFORMA 
Name of the patient: 
IP no: 
Age: 
Sex: 
Address: 
Occupation of the patient or Occupation of Patient’s Husband or Guardian: 
Family income per month: 
Literacy Status: 
Socio-Economic Status: 
Chief Complaints: 
1. Lump 
2. Pain 
3. Discharge from nipple 
4. Retraction of nipple 
Family History: 
Menstrual History: 
Marital History:   
 
Parity and Feeding History:  
 99 
 
Duration Of Symptoms: 
Time Interval Between Appearance Of Symptoms and First Visit To Hospital:  
Detection Of Lump by patient or medical practioner: 
Any prior visit to local hospital or prior investigations: 
Stage of tumor at time of admission: 
Investigations: 
1. FNAC 
2. Biopsy 
3. Mammogram 
4. Chest x-ray 
5. Ultra sound breast 
6. Ultra sound abdomen and pelvis 
7.CT  chest 
8.X-ray LS spine  
9.X-ray Pelvis 
10.X-ray Skull 
         
 
                                                                                                                                                                                     
KEY TO MASTER CHART 
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LITERACY STATUS.  
I = ILLITERATE 
P = PRIMARY EDUCATION 
S = SECONDARY EDUCATION 
HE = HIGHER EDUCATION 
SOCIO -ECONOMIC STATUS(SES) 
L = LOWER CLASS 
M = MIDDLE CLASS 
H = HIGHER CLASS 
DS= DURATION OF SYMPTOMS IN MONTHS 
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MASTER CHART 
SL.NO NAME I.P. NO AGE LITERACY SES DS  TNM 
STAGE 
GROUPING 
1 SHAILIA BEGAM 001223 43 p L 8 T3 N1 M0 III 
2 AANDAL 001245 60 I L 10 T2 N2 M0 III 
3 NACHIAR 001248 46 I L 12 T3 N2 M0 III 
4 SARASWATHY 001708 38 p L 9 T3 N1 M0 III 
5 JAYARANI 0021231 56 I L 4 T2N0M0 II 
6 JEYANTHI 002761 41 p L 8 T3N1M0 III 
7 MALLIGA 004791 56 l L 9 T3N2M0 III 
8 JANAKI 005471 62 l L 7 T3N1M0 III 
9 SELVI 006472 62 I L 6 T3N1M0 III 
10 MARIAMMAL 008710 45 p L 12 T3N2M0 III 
11 SARADHADEVI 008712 58 I L 8 T2N2MO III 
12 VIJAYALAKSMI 009408 54 I L 12 T4N1M0 III 
13 AMUDHA 009935 38 p L 4 T3NIM0 III 
14 JEYA 0012156 46 I L 8 T3N2M0 III 
15 MEENAKSHI 0012426 46 I L 8 T3N1M0 III 
16 AMUDHAVALI 0012706 31 p L 2 T2N0M0 II 
17 VELLAMMAL 0012780 26 I L 11 T3N2M0 III 
18 VEDHAMMAL 0013534 45 I L 7 T4N0M0 III 
19 KANJANADEVI 0017220 36 S M 2 T2N0M0 II 
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20 VIJAYA 0018766 59 I L 9 T4N1M0 III 
21 VENI 0020937 42 P L 6 T3N2M0 III 
22 ANNAKODI 0033722 48 I L 4 T2N0M0 III 
23 SUNDARAVALLI 0033899 46 P L 8 T3N1M0 III 
24 VIJI 0033995 47 I L 9 T3N2M0 III 
25 PIDARI 0035836 55 I L 10 T4N1M0 III 
26 JEYAPONNU 0043880 35 P L 7 T3N1M0 III 
27 SEENIAMMAL 0043976 70 I L 11 T3N1M0 III 
28 NAGASUNDARI 0044214 46 I L 5 T3NIM0 III 
29 MAHESWARI 0044375 46 I L 24 T4N3M1 IV 
30 MAYILU 0054369 29 P L 4 T2N0M0 II 
31 MUTHULAKSMI 0044358 46 P L 2 T2N0M0 II 
32 UMA 0044708 54 I L 12 T4N3M1 IV 
33 VEERAMMAL 0045213 62 I L 12 T4N1M0 III 
34 GANDHIMATHI 0045684 53 I L 12 T4N2M0 III 
35 LAKSHMI 0049055 31 P L 2 T2N0M0 II 
36 CHITRA 0049207 45 I L 6 T3N1M0 III 
37 PANDIMEENA 0050964 46 P L 12 T3N2M0 III 
38 MASILAMANI 0052615 45 I L 12 T4N0M0 III 
39 SAVITHRI 0052640 46 P L 3 T2N0M0 II 
40 BAGYAVATHI 0053147 35 I L 9 T3N1M0 III 
41 SHANTHI 0054261 38 P L 5 T2N0M0 II 
42 KASTHURI 0053022 63 I L 6 T3N1M0 III 
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43 MANORAMA 0046051 53 S M 2 T2N0M0 II 
44 PANDHANAM 0053261 37 I L 10 T3N1M0 III 
45 SABITHA 0054529 45 P L 3 T2N0M0 II 
46 KAVITHA 0054975 53 I L 8 T3N2M0 III 
47 DEVIKA 0055342 54 I L 9 T3N2M0 III 
48 LAKSMIRANI 0055510 46 S L 6 T3N1M0 III 
49 NAGARANI 0055761 45 P L 2 T2N0M0 II 
50 MUTHAYEE 0055741 43 I L 12 T4N1M0 III 
51 SHANTHA 0055196 49 P M           1 T1N0M0 I 
52 SARADHA 0055320 40 S M 9 T3N1M0 III 
53 ELAVARASI 0056874 51 I L 8 T3N1M0 III 
54 RANI 0056894 40 I L 6 T3N1M0 III 
55 LATHA 0056904 54 P L 2 T2N0M0 II 
56 MUTHUSELVI 0057218 35 S M 3 T2N0M0 II 
57 PANCHU 0056944 68 I L 12 T4N1M0 III 
58 CHINNATHAI 0057407 45 I L 11 T3N2M0 III 
59 SUSHEELA 0054731 53 I L 5 T3N1M0 III 
60 VARADHAMMA 0058741 69 I L 7 T4N3M1 IV 
61 SANMUGAYEE 0057870 70 I L 12 T4N2M1 IV 
62 MEENAKA 0058491 49 I L 6 T3N1M0 III 
63 KANCHARAM 0058431 62 I L 12 T4N2M0 III 
64 KAMALA 0058871 45 S L 2 T2N0M0 II 
65 PETCHIAMMAL 0059357 60 I L 6 T3N1M0 III 
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66 CHITRADEVI 0059467 45 S M 3 T2N0M0 II 
67 CAUVERY 0059661 48 I L 4 T3N1M0 III 
68 GAYATHRI 0059944 51 P L 3 T2N0M0 II 
69 ALAMELU 0060186 70 I L 5 T3N1M0 III 
70 MURUGAMMAL 0060434 35 I L 1 T1N0M0 I 
71 NANDHINI 0060712 45 P L 4 T2N0M0 II 
72 ELAMMA 0060784 70 I L 14 T4N2M0 III 
73 MARY 0060434 35 P M 1 T1N0M0 I 
74 GANGA 0060812 59 I L 7 T3N1M0 III 
75 GOVINDHAMA 0060851 72 I L 8 T3N1M0 III 
76 PARVATHY 0061051 45 P L 14 T4N1M0 III 
77 KANI 0061218 45 P L 3 T2N0M0 II 
78 KAMATCHI 0061176 42 I L 5 T3N1M0 III 
79 DURGA 0061211 66 I L 6 T3N1M0 III 
80 POORNAM 0061920 45 S M 1 T1N0M0 I 
81 KANNAMMA 006193 53 I L 12 T4N2M0 III 
82 RUKMANI 00620009 48 I L 8 T3N1M0 III 
83 THILAGAM 0062114 58 P L 12 T4N2M0 III 
84 THILAGAVATHY 0062048 58 P L 4 T2N0M0 II 
85 PALANIAMMAL 0062121 45 I L 4 T2N0M0 II 
86 MEENAL 0062774 60 I L 9 T3N1M0 III 
87 SEETHA 0062567 50 P L 2 T2N0M0 II 
88 TAMILSELVI 0062891 31 P L 3 T2N0M0 II 
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89 ARIYAKANI 0062567 63 I L 7 T3N1M0 III 
90 ESAKIAMMAL 0063217 66 I L 8 T3N2M1 IV 
91 VASANTHI 0063291 49 P L 5 T2N0M0 II 
92 MANIMEGALAI 0063875 55 I L 3 T2N0M0 II 
93 NILA 0063814 60 I L 8 T3N1M0 III 
94 VASANTHA 0063291 49 S M 5 T3N1M0 III 
95 RAJALAKSHMI 0063884 50 P L 12 T4N3M1 IV 
96 KALIAMMAL 0063891 60 I L 11 T4N2M0 III 
97 FATHIMA 0064213 45 P L 5 T2N0M0 II 
98 ANNAM 0064128 56 I L 7 T3N1M0 III 
99 VALLI 0064525 57 I L 6 T3N1M0 III 
100 ALIMABEEVI 0065586 42 P L 3 T2N0M0 II 
101 VIJAYARANI 0065803 52 I L 5 T3N1M0 III 
102 SULOCHANA 0065841 45 P L 4 T2N0M0 II 
103 JENNI 0068911 50 P L 9 T4N2M0 III 
104 SAROJA 0066160 58 I L 3 T2N0M0 II 
105 THENAMMAL 0066298 45 I L 11 T4N2M0 III 
106 PETCHI 0067508 50 I L 12 T4N2M0 III 
107 ANANTHI 0067561 35 I L 6 T2N0M0 II 
108 KANCHANA 0067606 66 I L 7 T3N1M0 III 
109 KASIRANI 0067790 65 I L 8 T4N2M0 III 
110 NISHABEGAM 0068994 49 I L 24 T4N3M1 IV 
111 SUBBAMMAL 0069768 54 P L 6 T3N1M0 III 
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112 JAYALAKSMI 0070304 50 P L 2 T2N0M0 II 
113 SEEMA 0070304 46 I L 4 T2N0M0 II 
114 NAGAMMAL 0070963 64 I L 16 T4N2M0 III 
115 PRABAVATHY 0070970 42 P L 4 T2N0M0 II 
116 PREETHY 0070895 45 I L 6 T3N1M0 III 
117 DEVAGI 0071816 45 P L 8 T3N2M0 III 
118 IRULAYEE 0071188 53 I L 6 T2N0M0 II 
119 JOTHI 0071392 70 I L 10 T4N2M0 III 
120 THEDASELVAM 0072887 54 I L 9 T4N3M1 III 
121 POORNAM 0073102 50 I L 18 T4N1M0 III 
122 CHANDRA 0073130 45 S M 3 T2N0M0 II 
123 THILLAIAMMAL 0073147 51 I L 12 T4N2M0 III 
124 CHAKMADHA 0073226 53 I L 8 T3N2M0 III 
125 PAPPATHI 0073578 50 P L 6 T2N0M0 II 
126 KULANDAI 0073225 57 I L 5 T2N0M0 II 
127 MAYILAMMAL 0074060 50 I L 12 T4N2M0 III 
128 HAMEEDNISHA 0074061 56 I L 9 T4N1M0 III 
129 THANGAMMAL 0074164 70 I L 15 T4N1M0 III 
130 NALLAMMAL 0074165 55 I L 9 T4N2M0 III 
131 KAMALAM 0074939 48 P L 5 T2N2M0 II 
132 GANGAMMAL 0075282 45 I L 11 T4N2M0 III 
133 NEELA 0075155 48 P L 4 T2N0M0 II 
134 MEENAMMAL 0076197 65 I L 4 T2N0M0 II 
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135 SUBBU 0076492 54 I L 11 T4N2M0 III 
136 VEERATHAI 0075012 48 I L 8 T3N1M0 III 
137 MUTHUMARI 0075512 55 P L 2 T2N0M0 II 
138 KARUPAYEE 0076281 38 I L 3 T2N0M0 II 
139 SUMATHI 0076190 52 I L 5 T2N0M0 II 
140 BINNIAMMAL 0076202 50 I L 12 T4N2M0 III 
141 OOCHAMMAL 0076234 50 P L 5 T2N0M0 II 
142 AADHAMMAL 002327 56 I L 10 T4N1M0 III 
143 PONNUPAPPA 0076512 38 I L 2 T2N0M0 II 
144 RAMAKKAL 0076197 46 P L 4 T2N0M0 II 
145 ALAGAMMAL 0077492 58 P L 9 T4N2M0 III 
146 RAHIMANISA 0077507 57 I L 24 T4N3M1 IV 
147 PUSHPAM 0077427 55 P L 9 T4N2M0 III 
148 KALI 0082583 50 P L 5 T2N0M0 II 
149 PREMA 0088967 54 I L 12 T4N2M0 III 
150 GNANATHAI 0075488 51 P L 7 T3N1M0 III 
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